Found: 9
Select item for more details and to access through your institution.
Acknowledgement to Referees.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s40273-023-01343-x
- Publication type:
- Article
Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 41, doi. 10.1007/s40273-023-01318-y
- By:
- Publication type:
- Article
Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 117, doi. 10.1007/s40273-023-01320-4
- By:
- Publication type:
- Article
Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 5, doi. 10.1007/s40273-023-01317-z
- By:
- Publication type:
- Article
The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important Limitations.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 11, doi. 10.1007/s40273-023-01313-3
- By:
- Publication type:
- Article
Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 109, doi. 10.1007/s40273-023-01314-2
- By:
- Publication type:
- Article
A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 19, doi. 10.1007/s40273-023-01312-4
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 69, doi. 10.1007/s40273-023-01309-z
- By:
- Publication type:
- Article
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 1, p. 91, doi. 10.1007/s40273-023-01306-2
- By:
- Publication type:
- Article